Sandoz spin-off updates, comments on Gilenya generics in focus for Novartis Q3 earnings
Robert Way Swiss pharmaceutical giant Novartis (NYSE:NVS) is scheduled to announce Q3 earnings results on Tuesday, October 25th, before market ...
Robert Way Swiss pharmaceutical giant Novartis (NYSE:NVS) is scheduled to announce Q3 earnings results on Tuesday, October 25th, before market ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.